Auckland-based tissue regeneration biotech company Aroa Biosurgery is currently developing two new products it is hoping to launch in 2023, while investing to accommodate manufacturing that could support $100 million in revenues – triple its current forecast.
The two ‘dead space’ platform
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
